Adiponectin Testing Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 56.11 Bn

Forecast Year, 2035

USD 120.35 Bn

CAGR, 2026 - 2035

7.93%

Report Coverage

Global

What is the Adiponectin Testing Market Size?

The global adiponectin testing market size was calculated at USD 56.11 billion in 2025 and is predicted to increase from USD 60.56 billion in 2026 to approximately USD 120.35 billion by 2035, expanding at a CAGR of 7.93% from 2026 to 2035.The adiponectin testing market has been growing recently due to increasing obesity rates, metabolic syndrome, and cardiovascular issues. The rise of various other health issues also fuels the growth of the market. The precision observed in insulin testing sensitivity of the test is another major factor propelling the growth of the market. Technological advancements also support the growth of the market.

Market Highlights

• North America led the global adiponectin testing market with the largest market share of 40% in 2025.
• The Asia Pacific is observed to be the fastest-growing region in the foreseen period.
• By product type, the assay kits segment led the global market in 2025.
• By product type, the reagents and consumables segment is observed to be the fastest-growing in the foreseen period.
• By species type, the human segment led the market in 2025.
• By species type, the mouse/rat segment is observed to grow in the foreseen period.
• By end user, the research and academic institutes segment led the global adiponectin testing industry in 2025.
• By end user, the hospitals segment is expected to flourish in the foreseeable period.

What is the Adiponectin Testing Market?

The adiponectin testing involves measuring the levels of a hormone protein produced by fat cells. It has a major role in balancing insulin sensitivity, fat metabolism, and inflammation, which is helpful for the growth of the market. Low levels detected in the test are a clear indication of cardiovascular issues, type 2 diabetes, or metabolic syndrome. The precise testing in clinical research and testing is another major factor propelling the growth of the market. Advancements in assay technologies for more precise results help to fuel the research and development of the industry as well. Higher investments in metabolic syndrome and diabetes also help boost the growth of the market.

Role of Technology in the Growth of Adiponectin Testing Market

Advancements in technology have made a major contribution to the growth of the adiponectin testing industry. Technologies in the form of ELISA, Latex Enhanced Immunoturbidimetric Assay, Mass Spectrometry, Western Blotting, and Point-of-Care-Testing methods help the industry to get specific results and identify the root cause of the issue, further fueling the growth of the market. Such methods are accurate and helpful in testing standardized measurements of adiponectin levels, further fueling the growth of the industry.

Latex-enhanced methods are essential for quick results in healthcare facilities like hospitals and clinics. The market also observes growth due to higher usage of less-invasive treatment tools to improve patient compliance. Availability of advanced kits helps to get detailed results and is considered more precise compared to standard tests, further boosting the growth of the market.

Adiponectin Testing Market Trends

• Growing Metabolic Diseases- prevalence of cardiovascular issues, type 2 diabetes, obesity, and other similar metabolic issues is one of the major factors for the growth of the market. The adiponectin testing helps in measuring the insulin levels and allows one to begin treatments in a timely manner to avoid worsening of the condition.
• Higher Demand for Accurate Results- the adiponectin testing helps to provide accurate results, indicating insulin and fat levels helpful to manage health issues, further fueling the growth of the market.
• Technological Advancements- the use of technologically advanced methods, which are helpful to get accurate results along with maintaining cost efficiency, is another major factor propelling the growth of the market.
• Rising Health Awareness- post-pandemic people have been concerned about their health vitals. Hence, higher demand for diagnostic testing to ensure smooth health vitals and manage the disturbed issues in time is another major factor fueling the growth of the market.

Market Scope

Segmental Insights

Product Type Insights

Why did the Assay Kits Segment lead the Global Adiponectin Testing Market in 2025?

The assay kits segment led the global adiponectin testing industry in 2025 due to their precise and accurate results in identifying the insulin levels and managing the health issues with ease, which is helpful for the growth of the market. The growing prevalence of metabolic disorders in the form of health issues such as obesity, type 2 diabetes, and cardiovascular problems, leading to higher demand for accurate testing, is another major factor for the growth of the market. Use of Enzyme-Linked Immunosorbent Assays (ELISA) is useful in research and clinical diagnostics, also helping to boost the growth of the market. These kits are helpful to detect and quantify adiponectin in serum and plasma for correct results, which is further helpful for the growth of the market.

The reagents and consumables segment is observed to be the fastest growing in the adiponectin testing market in the foreseeable period due to higher demand for assay kits and other similar tools helpful to identify the exact adiponectin levels to manage various health issues. The market also observes growth due to the rising prevalence of different types of metabolic health issues affecting the lifestyle of such individuals. The market is also observed to grow lately as the segment focuses on specific antibodies, enzymes for signal amplification, and calibrators for accurate measurement in serum. Higher usage of such products by research and academic institutes and diagnostic labs further fuels the growth of the market in the foreseeable period.

Species Type Insights

Which Component of the Species Segment leads the Global Market in 2025?

The human segment led the global adiponectin testing market in 2025 due to the rising prevalence of metabolic disorders such as obesity, type 2 diabetes, and cardiovascular issues, affecting health majorly. Assay kits and various other kits are essential to identify the accurate insulin levels in aiding their timely management for healthy vitals, also helping to fuel the growth of the market. Extensive research and clinical interest in human adiponectin as a biomarker in cases of various health issues is another major factor propelling the growth of the market. The segment also observes growth due to higher demand for human adiponectin levels for human-specific testing to understand disease mechanisms and treatment responses, which also helps boost the growth of the market.

The mouse/rat segment is observed to be the fastest growing in the adiponectin testing market in the foreseen period due to higher demand for preclinical research in metabolic syndromes, obesity, diabetes, and cardiovascular problems. Such animal models are essential for testing adiponectin receptors and therapeutic interventions, further fueling the growth of the market in the foreseeable period. Use of high-sensitivity assays in preclinical studies, helpful for critical marking of any health issue, is another major factor that helps boost the growth of the market. The market also observes growth due to higher demand for accurate test results of adiponectin interaction with receptors and T-cadherin in mice for clinical studies, which is another major factor boosting the growth of the market in the foreseeable period.

End User Segment Insights

Why did the Research and Academic Institutes lead the Global Market in 2025?

The research and academic institutes segment led the global adiponectin testing market in 2025 due to the increasing number of research and studies to identify the role of adiponectin in metabolic regulation and disease pathogenesis. Such academic institutes have also expanded their testing capabilities to support translational research and biomarker discovery, further boosting the growth of the market. Grant funding and government support to such research institutes supporting cardiovascular and metabolic research also help to fuel the growth of the market. The expensive use of adiponectin testing for clinical research and studies is another major factor propelling the growth of the market. Growing research to find out the root causes and issues observed in obese people and people suffering from cardiovascular issues also helps to fuel the growth of the market.

The hospitals segment is observed to be the fastest growing in the adiponectin testing market in the foreseen period due to the growing number of patients suffering from metabolic issues such as heart problems, diabetes, or lifestyle-related health issues like obesity, in hospitals. It leads to higher demand for adiponectin testing to identify the insulin levels in such patients and get accurate results for suggesting ideal treatment options, further fueling the growth of the market. Hence, it also leads to higher usage of immunoassay kits and ELISA, further propelling the growth of the market. The market also observes growth due to the availability of professional doctors and technologically advanced equipment. Factors such as the rapid prevalence of metabolic diseases and growing health awareness post-pandemic are also vital factors contributing to the growth of the market in the foreseeable period.

Regional Insights

How Big is the North America Adiponectin Testing Market Size?

The North America adiponectin testing market size is estimated at USD 22.44 billion in 2025 and is projected to reach approximately USD 548.74 billion by 2035, with a 8.07% CAGR from 2026 to 2035.

Why did North America lead the Global Adiponectin Testing Market in 2025?

North America led the global market in 2025 due to the rising prevalence of lifestyle-related and major health issues impacting the lifestyles of the citizens of the region. Hence, it leads to higher demand for the diagnosis of such diseases, further propelling the growth of the market. Adiponectin is a crucial biomarker for metabolic syndrome, insulin sensitivity, and inflammation observed in the region on a larger scale, boosting the growth of the market. Use of assay kits and other similar tools to identify the insulin levels and manage the conditions promptly also helps propel the growth of the market. Growing lifestyle-related health issues leading to higher demand for timely and accurate testing are another major factor propelling the growth of the industry. Higher contributions from research, academic institutes, and clinical labs also help to fuel the growth of the market.

What is the Size of the U.S. Adiponectin Testing Market?

The U.S. adiponectin testing market size is calculated at USD 2 billion in 2025 and is expected to reach nearly USD 4 billion in 2035, accelerating at a strong CAGR of 2% between 2026 and 2035.

The U.S. Adiponectin Testing Market Trends

The U.S. has a major contribution to the growth of the market due to biomarker-driven diagnosis of lifestyle-related health issues such as obesity, heart problems, and diabetes in the region. Rising health awareness in the region post-pandemic and timely tests to identify any health issues are another major factor boosting the growth of the market. Analysing fat metabolism and insulin sensitivity of a healthier lifestyle also helps to elevate the growth of the market in the region. Higher usage of assay kits, reagents, and consumables for accurate results of the diagnostic tests also helps to fuel the growth of the market.

Why is the Asia Pacific observed to be the fastest-growing region in the Foreseen Period?

Asia Pacific is observed to be the fastest-growing region in the adiponectin testing market in the foreseen period due to factors such as growing metabolic disorders in various forms and higher demand for diagnostic tools to analyse the issues and help in their timely management. The growing geriatric population and growing risks of metabolic issues in the population, leading to higher demand for various essential tests, also help to fuel the growth of the market in the foreseeable period. Growing research institutions equipped with diagnostic labs and the availability of assay kits and other diagnostic tools also help to fuel the growth of the market. Rising health awareness and improving healthcare infrastructure are other major factors propelling the growth of the market in the foreseeable period.

India Adiponectin Testing Market Trends

India has a major contribution to the growth of the market, mainly due to factors such as growing metabolic health issues, such as obesity, diabetes, and cardiovascular problems. The market also observes growth due to the availability of essential diagnostic tools and tests helpful for the timely detection and management of such disorders, propelling the growth of the market. Rising preventive healthcare and improved healthcare infrastructure in the country also help to fuel the growth of the market.

Adiponectin Testing Market Value Chain Analysis

Who are the Major Players in the Global Adiponectin Testing Market?

The major players in the adiponectin testing market include Merck KGaA (MilliporeSigma), Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Eagle Biosciences, Inc., STRATEC SE, Boster Biological Technology, Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Trinity Biotech plc, ERBA Diagnostics, Inc., Zeus Scientific Inc., Stratech, Laboratory Corporation of America Holdings (LabCorp), Abcam, R&D Systems, Abnova, Mindray

Segments Covered in the Report

By Product Type

• Assay Kits
• Reagents & Consumables

By Species Type

• Human
• Mouse
• Rat
• Others

By End User

• Research & Academic Institutes
• Hospitals
• Diagnostic Labs

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa